No abstract available
MeSH terms
-
Administration, Oral
-
Animals
-
Anti-Inflammatory Agents / administration & dosage
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Drug Delivery Systems
-
Drug Design*
-
Humans
-
Integrin alpha4 / metabolism
-
Leukocytes / drug effects
-
Leukocytes / metabolism
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
-
Multiple Sclerosis, Relapsing-Remitting / metabolism
-
Natalizumab
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Natalizumab
-
Integrin alpha4